Cargando…
DrugComboRanker: drug combination discovery based on target network analysis
Motivation: Currently there are no curative anticancer drugs, and drug resistance is often acquired after drug treatment. One of the reasons is that cancers are complex diseases, regulated by multiple signaling pathways and cross talks among the pathways. It is expected that drug combinations can re...
Autores principales: | Huang, Lei, Li, Fuhai, Sheng, Jianting, Xia, Xiaofeng, Ma, Jinwen, Zhan, Ming, Wong, Stephen T.C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4058933/ https://www.ncbi.nlm.nih.gov/pubmed/24931988 http://dx.doi.org/10.1093/bioinformatics/btu278 |
Ejemplares similares
-
Stochastic EM-based TFBS motif discovery with MITSU
por: Kilpatrick, Alastair M., et al.
Publicado: (2014) -
Using association rule mining to determine promising secondary phenotyping
hypotheses
por: Oellrich, Anika, et al.
Publicado: (2014) -
Editorial
por: Batzoglou, Serafim, et al.
Publicado: (2014) -
Graph-regularized dual Lasso for robust eQTL mapping
por: Cheng, Wei, et al.
Publicado: (2014) -
Functional association networks as priors for gene regulatory network inference
por: Studham, Matthew E., et al.
Publicado: (2014)